ライフサイエンスコーパス: -producing cell

1 Immunocytostaining showed that ET-1-producing cells emerged only in PBMCs stimulated with an

2 further implicate GC TFH as the major HIV-1-producing cells in chronic asymptomatic HIV-1 infection.

3 Blocking this pathway in HIV-1-producing cells resulted in less infectious progeny viri

4 ent arms led to induction of dual IL-4/IL-10-producing cells during the pollen season.

5 at neutrophils made up the majority of IL-10-producing cells in circulation and in secondary lymphoid

6 tive IL-10 and suggest interference by IL-10-producing cells in the detection of drug-specific T cell

7 stimulation and increased induction of IL-10-producing cells of several types, including Tr1 cells, f

8 acrophages (Mvarphis) constituted most IL-10-producing cells.

9 emical evidence of apoptotic cells and IL-15-producing cells proximal to B-CLL pseudofollicles in pat

10 into proinflammatory interleukin-17 (IL-17)-producing cells by inflammatory mediators and thereby lo

11 reduced the number of interleukin-17 (IL-17)-producing cells in the intestine and production of granu

12 s are a population of interleukin 17 (IL-17)-producing cells that acquire effector function in the th

13 ly differentiate into interleukin-17 (IL-17)-producing cells.

14 They decreased IL-17-producing cells and increased the level of circulating I

15 is via the direct regulation of dermal IL-17-producing cells and stimulation of keratinocytes for amp

16 IL-17-producing cells are important mediators of graft-versus-

17 Most IFN-gamma- and IL-17-producing cells expressed high levels of CD226, but prod

18 re sources of IFN-gamma and IL-17, and IL-17-producing cells expressed RORgammat.

19 ORgammat, enabling the conversion into IL-17-producing cells in response to IL-1beta and IL-23.

20 +) cells represent the major source of IL-17-producing cells in the gingiva.

21 Loss of IL-17-producing cells in the gut during HIV infection is linke

22 -17 and underlying mechanisms by which IL-17-producing cells promote human colorectal cancer (CRC) re

23 IFN-gamma and IL-17-producing cells specific for the hemagglutinin and nucle

24 rrelates with increased frequencies of IL-17-producing cells within these T cell populations.

25 erols, showed significant reduction of IL-17-producing cells, including CD4(+) and gammadelta(+) T ce

26 Intestinal IL-17-producing cells, including Th17, gamma/delta T, and inna

27 ffects on inhibition of IFN-gamma- and IL-17-producing cells.

28 Percentages of interleukin 17-producing cells were significantly higher in spleen and

29 mma (IFN-gamma) and interleukin 17A (IL-17A)-producing cells are described to be related to the prote

30 ence of IkappaBNS, the frequencies of IL-17A-producing cells are drastically reduced.

31 lungs had an increased percentage of IL-17A-producing cells compared with that of TCRdelta(-/-) mice

32 A significantly lower fraction of IL-2-producing cells and a decrease in functional avidity and

33 Here, we report that the majority of IL-2-producing cells in the thymus are mature CD4 single-posi

34 ansfected with IL-2, suggesting that in IL-2-producing cells signaling may already take place before

35 could provide help to neighboring, non-IL-2-producing cells to differentiate into IFN-gamma-producin

36 ouse models that the relative number of IL-2-producing cells within Ag-specific CD8(+) T cell populat

37 ells can be divided into IFN-gamma- and IL-2-producing cells.

38 A variety of IL-22-producing cell types is known, but identification on the

39 that would allow the identification of IL-22-producing cells and their fate mapping in vivo.

40 Depleting IL-22-producing cells during the healing phase impaired epithe

41 secretion assays detecting IL-17A- and IL-22-producing cells in a single purification step.

42 n between the gut microbiome and IL-17/IL-22-producing cells plays a role in the development of metab

43 re, an increase in proportion of these IL-23-producing cells was detected only in tumor models where

44 ustained reduction in allergen-specific IL-4-producing cell counts (P < .01).

45 4 and constitute up to 70% of the total IL-4-producing cells during the initial stages of infection.

46 e were no differences in frequencies of IL-4-producing cells within any of the memory compartments co

47 IgG4 (sIgG4) levels and an increase in IL-4-producing cells, followed by downregulation of the TH2 r

48 or the conditional deletion of distinct IL-6-producing cell types to show that dendritic cells (DCs)

49 blast IL-6 regulation, but not in other IL-6-producing cell types.

50 To what extent IL-9-producing cells are induced or regulated by sensitizatio

51 pecific cytokine IL-5 suggests that the IL-9-producing cells belong to the recently described TH9 sub

52 e NF-B cells have the potential to become Ab-producing cells and to undergo class-switch recombinatio

53 There are fewer IgG1 Ab-producing cells in the bone marrow of cKOs.

54 nic stimulation and their transition into Ab-producing cells.

55 h T cells, and their differentiation into Ab-producing cells.

56 but rather by the adipokinetic hormone (AKH)-producing cells of the corpora cardiaca, and we demonstr

57 other extends to adipokinetic hormone (AKH)-producing cells to inhibit secretion of AKH, the fly ana

58 Furthermore, activation of AKH-producing cells alone was sufficient to enhance longevit

59 CYP11B2-expressing cells, called aldosterone-producing cell clusters, were analyzed.

60 CYP11B2 expression and increased aldosterone-producing cell cluster expression.

61 The integrated ratio of aldosterone-producing cell cluster to CYP11B2-expressing area was mo

62 Recently, aldosterone-producing cell clusters (APCCs) with high expression of

63 31, P<0.0001), whereas the total aldosterone-producing cell cluster area was positively correlated wi

64 and tumor necrosis factor alpha (TNF-alpha)-producing cells displaying the highest and lowest preval

65 quencies of tumor necrosis alpha (TNF-alpha)-producing cells, whereas atypical MBCs expressed high le

66 alance between pDC maturation into IFN-alpha-producing cells or development of an APC phenotype diffe

67 with an APC phenotype rather than IFN-alpha-producing cells.

68 ells, including normally low-level IFN-alpha-producing cells.

69 of IL-4-, IL-17-, IFN-gamma-, and TNF-alpha-producing cells compared with T cells lacking CD20.

70 The spectrum of TNF-alpha-producing cells in patients with psoriasis, as well as t

71 PV23]), IgG anti-caps-PS serotype 4 antibody-producing cells resided mainly in the CD19(+) CD5(-) B c

72 by which removal of antibodies and antibody-producing cells improve neurological function, and offer

73 However, the role of B cells beyond antibody-producing cells is less well defined.

74 The identification of GAD-antibody-producing cells has implications for the selection of ce

75 ood that readily differentiate into antibody-producing cells.

76 in the immune system, in particular antibody-producing cells and B lymphocytes.

77 ces, and the loss of HIV-1-specific antibody-producing cells during development.

78 serious pathologies of B cells, the antibody-producing cells of the immune system.

79 y analysis revealed that the nucleoid in ArT-producing cells is concentrated and appears hollow.

80 lls also more readily generated autoantibody-producing cells than HSPCs with lower levels of ARID3a i

81 cting not only as precursors of autoantibody-producing cells but also as antigen-presenting, cytokine

82 ns and as a potential source of autoantibody-producing cells in autoimmune diseases such as systemic

83 AFF is produced in vivo and about which BAFF-producing cells contribute to B cell responses.

84 FP reporter mice, we identify these IFN-beta-producing cells in the spleen as a CCR9(+)CD9(-) pDC sub

85 y require the development of single biologic-producing cell lines followed by their cultivation at ve

86 ociated lymphoid tissue (BALT), where VEGF-C-producing cells were scattered in T-cell zones.

87 c cells in the kidney were detected as CCL18-producing cells.

88 sing the possibility that CCL18 and/or CCL18-producing cells may interfere with their reconstitution

89 Collagen-producing cells maintain the complex architecture of the

90 cell RNA-sequencing to identify all collagen-producing cells in normal and fibrotic lungs.

91 In conclusion, loss of Twist1 in collagen-producing cells led to increased bleomycin-induced pulmo

92 ollagen synthesis by HSCs, the main collagen-producing cells in liver fibrosis.

93 Our atlas of collagen-producing cells provides a roadmap for studying the role

94 and have a higher concentration of collagen-producing cells.

95 ables have unique interactions with collagen-producing cells.

96 However, the molecular properties of GM-CSF-producing cells and the mode of Csf2 regulation in vivo

97 llow the purification of any single cytokine-producing cell subset, and the combination of several di

98 s suppress the generation of type 2 cytokine-producing cells in the lungs.

99 nes because both cytokine input and cytokine-producing cells play key roles.

100 and infer that the differentiated, cytokine-producing cells cycle faster than early activated precur

101 ry T (Treg) cells into inflammatory cytokine-producing cells is thought to be an important step in th

102 we measured significant numbers of cytokine-producing cells even in unexposed individuals.

103 Phenotypic characterization of cytokine-producing cells was performed by FACS.

104 f CD8 T cells and the generation of cytokine-producing cells were significantly reduced by the lack o

105 differentiation into polyfunctional cytokine-producing cells.

106 genes of SoxN that are expressed in denticle-producing cells and that are regulated independently of

107 neural crest cells give rise to the dentine-producing cells (odontoblasts) of teeth.

108 cilitate planning of transplants of dopamine-producing cells derived from human pluripotent stem cell

109 nd predominantly the IL-17(+)IL-10(+) double-producing cells, were markedly refractory to the inhibit

110 17 cells give rise to IL-17/IFN-gamma double-producing cells and Th1-like IFNgamma(+) ex-Th17 lymphoc

111 ion of Th17 cells to IL-17A/IFN-gamma double-producing cells as well as Th1-like IFN-gamma(+) ex-Th17

112 on the generation of IL-17/IFN-gamma double-producing cells, but leads to a marked absence of Th1-li

113 (IL-17A)- and interferon (IFN)-gamma-double-producing cells that are implicated in development of au

114 ighly expressed in stromal cells next to Dpp-producing cells and functions to remove excess Dpp outsi

115 the role of the PHD/HIF-2 axis in renal EPO-producing cell (REPC) plasticity is unclear.

116 n a previously unrecognized reservoir of Epo-producing cells (EPCs), leading to expansion of the eryt

117 In human erythropoietin-producing cells, hCMV inhibited hypoxia-induced expressi

118 -like cells resembling native erythropoietin-producing cells located in the tubulointerstitium.

119 Renal erythropoietin-producing cells (REPCs) remain in the kidneys of patient

120 gical stimuli of angiogenic phenotypes in EV-producing cells can enhance the potency of EVs for vascu

121 ence for a significant expansion of IL-17A/F-producing cells in mouse liver within 24 h of adenovirus

122 st a mechanism for the coordination of force-producing cell behaviors across the embryo.

123 g ASFV-specific gamma interferon (IFN-gamma)-producing cells.

124 An expansion of IFN-gamma-producing cells and intracytoplasmic IFN-gamma levels wa

125 ing review, we discuss the role of IFN-gamma-producing cells and the signals that regulate IFN-gamma

126 n; however, the mechanism by which IFN-gamma-producing cells are recruited to the sites of inflammati

127 initial step in the chemotaxis of IFN-gamma-producing cells in chemically induced skin inflammation.

128 rare population of nonconventional IFN-gamma-producing cells of hematopoietic origin that were charac

129 ficantly lower frequency of CLA(+) IFN-gamma-producing cells was observed in patients with AD, with n

130 days 4 and 7 postimmunization, and IFN-gamma-producing cells were detected in all pigs analyzed follo

131 Shortly after challenge, IFN-gamma-producing cells were highly enriched for Ly6C(+)T-bet(+)

132 lood-derived Tregs into IL-17- and IFN-gamma-producing cells, even in the presence of the IL-17-drivi

133 otential protective role for these IFN-gamma-producing cells.

134 ressing (DT) mice that specifically lack GIP-producing cells were backcrossed five to eight times ont

135 ells at the expense of insulin- and glucagon-producing cells during endocrine cell development.

136 Depleting histamine-producing cells enforces cell cycle entry, induces loss

137 coordinated development of distinct hormone-producing cell types and an invading vascular network.

138 ior pituitary harbours five distinct hormone-producing cell types, and their cellular differentiation

139 Whilst traditionally considered hormone-producing cells, there is evidence that they also initia

140 hormone and proliferation of growth hormone-producing cells.

141 Intestinal hormone-producing cells represent the largest endocrine system i

142 t pancreata, but fail to mature into hormone-producing cells.

143 owth, but not the differentiation of hormone-producing cells.

144 docrine progenitor cells and progeny hormone-producing cells, indicating that Area II activity is fun

145 reduction in numbers of most of the hormone-producing cells before birth, with the exception of cort

146 DCs) are the major type I interferon (IFN-I)-producing cells, and IFN-I actually contributes to patho

147 tic cells (pDCs) are the most powerful IFN-I-producing cells and play important roles during viral in

148 , they are not considered professional IFN-I-producing cells.

149 We define "professional type I IFN-producing cells" as a distinct subset of pDCs specialize

150 een regarded as the "professional type I IFN-producing cells" of the immune system following viral re

151 In parallel, human pDCs are potent IFN-producing cells upon MERS-CoV infection.

152 stand the selective pressures shaping the Ig-producing cell repertoire in the parotid glands of prima

153 ssues, IgG was the dominant isotype among Ig-producing cells, and 60% of IgG-positive cells produced

154 on of human peripheral blood B cells into Ig-producing cells, we aimed to study the role of ROS gener

155 The Ig-producing cells and the proportion of cells producing Ga

156 fewer B cells, and they are enriched for IgA-producing cells.

157 oreover, the proportion of Gal-deficient IgG-producing cells directly correlated with clinical parame

158 d differentiation into non-NTHi-specific IgM-producing cells.

159 ing, interleukin 6 (IL6)-producing, and IL17-producing cells was greater in ALR-H-KO than ALR-H-HET a

160 of CD4(+) T cells into IFN-gamma- and IL17A-producing cells, and that both T-cell phenotypes are lin

161 plasic, with an increased number of incretin-producing cells compared with the corresponding jejunal

162 at modulation of the development of incretin-producing cells in the intestine has potential as a ther

163 rogels for both insulin delivery and insulin-producing cell therapies for type 1 diabetes management.

164 Insulin-producing cells derived from human embryonic stem cells

165 ations of activity in LK neurons and insulin-producing cells (IPCs) in adult flies and monitored food

166 ies to characterize human islets and insulin-producing cells differentiated from embryonic stem cells

167 endothelial cells, hepatocytes, and insulin-producing cells differentiated from hPSCs, respectively.

168 HNF4 is required in the fat body and insulin-producing cells to maintain glucose homeostasis by suppo

169 ced pluripotent stem cells to create insulin-producing cells from individuals with Wolfram syndrome.

170 These rats developed insulin-producing cells within the upper intestine in numbers su

171 Replication of differentiated insulin-producing cells is the major source of new beta-cells in

172 We found that Drosophila insulin-producing cells (IPCs), which are located in the pars in

173 pancreas can give rise to endocrine insulin-producing cells upon ectopic expression of key transcrip

174 s is an evidence for extrapancreatic insulin-producing cells.

175 sphinganine is a cytotoxic lipid for insulin-producing cells, suggesting that the increased levels of

176 n varies, making it hard to sort for insulin-producing cells.

177 ponse to dietary conditions, but how insulin-producing cells (IPCs) coordinate their responses to dis

178 However, insulin-producing cells previously generated from human pluripot

179 unlimited source of functional human insulin-producing cells and 2) prevention of rejection without t

180 erized and unlimited source of human insulin-producing cells.

181 g, the iDTZ compound concentrated in insulin-producing cells and proved effective at delineating zinc

182 rmined that GX sPLA2 is expressed in insulin-producing cells of mouse pancreatic islets and investiga

183 overload, underlie glucotoxicity in insulin-producing cells.

184 rowth by direct differentiation into insulin-producing cells and by mitigating the cytotoxicity of in

185 that efficiently converts hESCs into insulin-producing cells.

186 an embryonic stem cells (HESCs) into insulin-producing cells.

187 es (T1D) involves replacing the lost insulin-producing cells with new ones, preferably cells from a w

188 that the pancreas reconstitutes new insulin-producing cells in the absence of autoimmunity.

189 etes requires an unlimited source of insulin-producing cells and the ability to block the pathologica

190 lock in the regenerative capacity of insulin-producing cells following genetic ablation of beta cells

191 e advances in the differentiation of insulin-producing cells from human embryonic stem cells, the gen

192 trace and quantify the formation of insulin-producing cells in HPS from both non-diabetic and type 2

193 insulin genes nor the development of insulin-producing cells in vitro.

194 ls and histopathological evidence of insulin-producing cells or molecular markers of endocrine tissue

195 ls and histopathological evidence of insulin-producing cells or molecular markers of endocrine tissue

196 ons largely disabled the response of insulin-producing cells to glucose and dilp2 secretion, disinhib

197 tion or gut organoids as a source of insulin-producing cells to treat human diabetes.

198 concerns include immunoisolation of insulin-producing cells with porous biomaterials that function a

199 ls to generate a renewable source of insulin-producing cells.

200 ed in plasma and almost no remaining insulin-producing cells were present in the pancreas.

201 1D, assuming that glucose-responsive insulin-producing cells are available for transplantation.

202 ferentiated into glucose-responsive, insulin-producing cells by ablation of transcription factor Foxo

203 ansplantation of glucose-responsive, insulin-producing cells offers the potential for restoring glyce

204 at select expression of dfmr1 in the insulin-producing cells (IPCs) of the brain was sufficient to re

205 quirement for the Lk receptor in the insulin-producing cells (IPCs), suggesting LHLK-IPC connectivity

206 (OPNs) and not in the ovaries or the insulin-producing cells (IPCs).

207 o 7 median neurosecretory cells: the insulin-producing cells (IPCs).

208 e mutation or diabetes status, these insulin-producing cells are immature, a common downfall off most

209 One axon branch projects to insulin-producing cells to trigger the release of Drosophila ins

210 Generation of transplantable insulin-producing cells from human embryonic stem cells or induc

211 ell as the viability of transplanted insulin-producing cells.

212 trieved after 174 d contained viable insulin-producing cells.

213 inhibitory neurons that synapse with insulin-producing cells.

214 Gamma interferon-producing cells peaked at day 24 postimmunization, decli

215 dendritic cells (pDC) are type I interferon-producing cells with critical functions in a number of h

216 mine whether GPR30 colocalizes with isotocin-producing cells in the preoptic area, a critical node in

217 The implantation of such levodopa-producing cells can concurrently decrease the elevated m

218 Sonic Hh (Shh) ligand-producing cells and Shh-responsive cells were quantified

219 ceous gland, sebocytes are specialized lipid-producing cells that can release inflammatory mediators.

220 This analysis enabled us to map all matrix-producing cells at high resolution, and to identify dist

221 expressed in surfactin-producing and matrix-producing cells, respectively.

222 nteraction of surfactin-producing and matrix-producing cells.

223 on of T cells and bone marrow-derived matrix-producing cells.

224 enhances nutrient uptake, and enables matrix-producing cells to outcompete non-matrix-producing cheat

225 ts, which are the major extracellular matrix-producing cells of the heart.

226 ogies, as a mediator of extracellular matrix-producing cells.

227 their substrate, thereby facilitating matrix-producing cells to form bundles.

228 nd tapA; these genes are expressed in matrix-producing cells.

229 McC-producing cells also induce persistence in sensitive cel

230 McC-producing cells have increased persistence levels due to

231 Choroidal melanocytes (HCMs) are melanin-producing cells in the vascular uvea of the human eye (i

232 These MMP12-producing cells showed reduced surface levels of the coi

233 ed the presence of ciliated cells over mucus-producing cells and decreased myofibroblast numbers, eve

234 MUC5AC-containing mucus gel domains to mucus-producing cells in the epithelium.

235 yticus strain UCN34, adhered better to mucus-producing cells such as HT-29-MTX than to the parental H

236 of interferon gamma (IFNG)-producing and non-producing cells purified by flow cytometry.

237 tablishing a stable trans-complementing NSP5-producing cell line required to rescue rotaviruses with

238 Neutrophils are a major source of OSM-producing cells in patients with CRS and severe asthma.

239 y revealed distinct populations of HIV-1 p24-producing cells in BM early after infection, and quantif

240 nocytes are the neural crest-derived pigment-producing cells of the skin that possess dendrites.

241 he melanocytic lineage, highlighting pigment-producing cells as the melanoma cell of origin, and indi

242 sitive cells, continuous loss of the pigment-producing cells from the epidermis, and development of v

243 rest-derived cells that generate the pigment-producing cells of our body.

244 tive CD8(+) T cells that destroy the pigment-producing cells of the epidermis, melanocytes, leading t

245 ineage analysis of ommochrome- and porphyrin-producing cells in the brown, freshwater planarian Schmi

246 eceptor 2 (VEGFR2) expressed in PD prolactin-producing cells known to impair gonadotrophin secretion.

247 alized jugular vein delivery of prostacyclin-producing cells may provide sustained therapeutic effect

248 regulated VEGF expression in cultured renin-producing cells.

249 ney and can differentiate into JG-like renin-producing cells under conditions that promote JG cell re

250 e a dramatic increase in the number of renin-producing cells in the kidney, termed JG cell recruitmen

251 ciate with hyperplasia or expansion of renin-producing cells, but it is unknown whether hypoxia-trigg

252 sma virus was associated with each HIV-1 RNA-producing cell in women as compared to men, suggesting t

253 Women had marginally fewer HIV-1 RNA-producing cells (mean, 0.21 cells/mm(2)) than men (mean,

254 ter adjusting for the frequency of HIV-1 RNA-producing cells and potential confounders, the viral loa

255 The frequencies of HIV-1 RNA-producing cells in the lymph node were determined by in

256 edict viral load or frequencies of HIV-1 RNA-producing cells, indicating that physiologic levels of C

257 human gut endocrine progenitor and serotonin-producing cells.

258 Instead, we find that SHH-producing cells signal at short range via membrane-bound

259 s the additional digit to arise from the Shh-producing cells of the polarizing region - an ability lo

260 specific subset of cells lying near the SHH-producing cells, even though there is an abundance of li

261 sicles along cytonemes emanating from signal-producing cells to form a gradient in Drosophila epithel

262 are more likely to differentiate into signal-producing cells.

263 ptomatic infection prior to simian AIDS, SIV-producing cells were more concentrated in follicular (F)

264 ymphoid B cell follicles, where HIV- and SIV-producing cells are most highly concentrated, indicating

265 ot able to clear all follicular HIV- and SIV-producing cells.

266 of CD8 depletion on levels of follicular SIV-producing cells in chronically SIV-infected rhesus macaq

267 ntly, after CD8 depletion, the number of SIV-producing cells increased in B cell follicles and extraf

268 on, there was no compartmentalization of SIV-producing cells.

269 tent allowed us to rapidly determine the STX-producing cell concentrations of two Alexandrium species

270 of lung alveoli and serve as the surfactant-producing cells of air-breathing organisms.

271 We propose that surfactin-producing cells reduce the friction between cells and th

272 via transplantation and reestablishment of T-producing cell lineages in the body.

273 Thus, there is a need to obtain T-producing cells that could be used to treat hypogonadism

274 nterferon (IFN)-gamma (Th1) and IL-17 (Th17)-producing cells.

275 sis and later differentiation of hard tissue-producing cells.

276 receptor, is predominantly expressed by TNF-producing cells, suggesting a novel cellular hierarchy f

277 aste cells, which are different from the TNF-producing cells in mouse circumvallate and foliate taste

278 alysis of diseased kidneys and purified UMOD-producing cells revealed early activation of the PKR-lik

279 VEGF164- and VEGF120-producing cells (fs164 and fs120 respectively) were less

280 The vesicle-producing cells induce MV formation in neighboring cells

281 stinct times and locations: (i) in the virus-producing cell prior to viral release, yielding a DNA-co

282 mino acid transporter-1 (mCAT1) in the virus-producing cell.

283 Whether GC TFH are the major HIV-1 virus-producing cells in vivo has not been established.

284 ells, as well as replication-competent-virus-producing cells, were measured to quantified viral repli

285 of HIV-1 DNA and replication-competent-virus-producing cells.

286 expression of either PSGL-1 or CD43 in virus-producing cells reduces the infectivity of progeny virio

287 IV-1 precursor Gag (PrGag) proteins in virus-producing cells using a biotin ligase-tagging approach.

288 reased HIV-1 Gag protein expression in virus-producing cells, while silencing the m(6)A erasers incre

289 sor of the Gag (Pr55(Gag)) of HIV-1 in virus-producing cells.

290 macrophages as the principal subset of virus-producing cells in BM over time.

291 The average number of virus-producing cells in peripheral blood is small during chro

292 enhancing immune-mediated clearance of virus-producing cells is of high priority.

293 Finally, treatment of virus-producing cells with Chk inhibitor protects them from vi

294 ion through the exocytic organelles of virus-producing cells, and second after virus binding to targe

295 cell-to-cell transmission because the virus-producing cells cannot be easily distinguished from infe

296 ages were a significant portion of the virus-producing cells found in LNs, intestinal tissues, and lu

297 from lymphoid B cell follicles, where virus-producing cells are most highly concentrated, suggesting

298 ene required for Wnt ligand secretion by Wnt-producing cells, specifically in the hair follicle epith

299 hat basal subclones recruit heterologous Wnt-producing cells to restore tumour growth.

300 opment, but the identity and role of the Wnt-producing cells are still unclear.